Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Virta Health's Diabetes Mission Is Personal For Its GC No Photo Available

Michele Gorman

Jamie Anderson said it's important to find a mission-driven company to join — and when that mission aligns with an attorney's personal... (more story)

Healthcare Hires: Ex-DOJ, Fresenius Attys On The Move No Photo Available

Gianna Ferrarin

An ex-federal prosecutor who led healthcare fraud investigations in Texas has joined Hicks Thomas LLP, and an attorney with in-house e... (more story)

A Trump Do-Over On 'Most Favored Nation' Drug Prices No Photo Available

Yeji Jesse Lee

President Donald Trump's move this week to "equalize" U.S. drug prices with lower overseas prices hearkens back to a similar effort ma... (more story)